protoporphyrin ix has been researched along with mitoxantrone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qian, T; Wang, Z; Yang, R; Yuan, Y; Zhou, Q | 1 |
| Connell, GJ; Liang, S | 1 |
2 other study(ies) available for protoporphyrin ix and mitoxantrone
| Article | Year |
|---|---|
Naphthyl quinoxaline thymidine conjugate is a potent anticancer agent post UVA activation and elicits marked inhibition of tumor growth through vaccination.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Quinoxalines; Structure-Activity Relationship; Thymidine; Ultraviolet Rays; Vaccination | 2019 |
Identification of specific inhibitors for a trypanosomatid RNA editing reaction.
Topics: Antiprotozoal Agents; False Positive Reactions; High-Throughput Screening Assays; Indoles; Inhibitory Concentration 50; Mitoxantrone; Models, Biological; Parasitic Sensitivity Tests; Phenols; Protein Synthesis Inhibitors; Protoporphyrins; RNA Editing; Sphingosine; Substrate Specificity; Suramin; Trypanosomatina | 2010 |